返回 Agenda
LS40 Promoting DX (Digital Transformation) in Risk Communication to Patients
Session Chair(s)
Kazuhiko Ishida, MSC, RPH
Director, Pharmacovigilance
Astellas Pharma Inc., Japan
Speaker(s)
Michiko Yamamoto, PHD
Graduate School of Kumamoto University, Japan
Pharmaceutical Sciences/Visiting Professor
Shinya Takemoto, MSC
Chugai Pharmaceutical Co., Ltd., Japan
Group Manager, Safety Information Strategy Group, Risk Communication Department